The CD200-tolerance Signaling Molecule Associated with Pregnancy Success is Present In Patients with Early-stage Breast Cancer but Does not Favor Nodal Metastasis

American Journal of Reproductive Immunology

Volumn 72, Issue 5, 2014, Pages 435-439

  Clark, David A ^a,b,c,d   Dhesy Thind, Sukhbinder ^e   Ellis, Peter ^e   Ramsay, Jennifer ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

CD200; Human breast cancer; Metastasis; Mouse breast cancer models; Pregnancy immunology; Tumor immunology

Indexed keywords

CD200 ANTIGEN; ANTIGENS, CD200; LEUKOCYTE ANTIGEN; TUMOR PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; LYMPH NODE METASTASIS; POSTOPERATIVE PERIOD; PREGNANCY; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VOLUME; AGED; BREAST TUMOR; GENE EXPRESSION REGULATION; HEK293 CELL LINE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PREGNANCY;

EID: 84908666975     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12297     Document Type: Article

References (25)

1. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bilger M, Song Y, Jenmalm M, Gorman D, McClanahan T, Liu MR, Brown MH, Sedgwick JD, Phillips JH, Barclay AN: Characterization of the CD200 receptor family in mice and humans and their interaction with CD200. J Immunol 2003; 171:3034-3046.
2. Gorczynski RM, Chen Z, Kai Y, Lei J: Evidence for persistent expression of OX-2 as a necessary component of prolonged renal allograft survival following portal vein immunization. Clin Immunol 2000; 97:69-78.
3. Gorczynski RM, Chen Z, He W, Khatri I, Sun Y, Yu K, Boudakov I: Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. J Immunol 2009; 183:1569-1568.
4. Gorczynski RM, Chan Z, Khatri I, Yu G: Graft-infiltrating cells expressing a CD200 transgene prolong allogeneic skin graft survival in association with local increases in Foxp3(+) Treg and mast cells. Transpl Immunol 2011; 25:187-193.
5. Clark DA, Gorczynski RM: Immunological tolerance/acceptance of the semiallogeneic embryo: decidual transforming growth factors and tolerance signaling molecules. In Immunology of Pregnancy 2013, G Chaouat, S Olivier, N Ledee (eds). Bentham eBooks (eISBN:978-1-60805-733-7), 2013, pp 540-558.
6. Clark DA, Chaouat G: Regulatory T cells and reproduction: how do they do it? J Reprod Immunol 2012; 96:1-7.
7. Moreau J, Veyrune JL, Reme T, De Vos J, Klein B: CD200: a putative therapeutic target in cancer. Biochem Biophys Res Commun 2008; 366:117-122.
8. Talebian F: CD200-CD200R interaction in tumor immunity. PhD Thesis, Ohio State University, 2012. http://rave.ohiolink.edu/etc./view?accnum=osu1331913293.
9. + T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: implications for immunotherapy. BMC Cancer 2008; 8:57-68.
10. Podnos A, Clark DA, Erin N, Yu K, Gorczynski RM: Further evidence for a role for human CD200 expression in breast cancer metastases in CD200R1KO mice. Breast Cancer Res Treat 2012; 136:117-127.
11. Clark DA: Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss. Am J Reprod Immunol 2009; 61:75-84.
12. Whiteside TL: Regulatory T cell subsets in human cancer: are they regulating for or against progression? Cancer Immunol Immunother 2014; 63:67-72.
13. Whiteside TL: Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumor-derived exosomes). Biochem Soc Trans 2013; 41:245-251.
14. Kshirsagar SK, Alam SK, Jasti S, Hodes H, Nauser T, Gilliam M, Billstrand C, Hunt JS, Petroff MG: Immunomodulatory molecules are released from the first trimester and term placenta via exosomes. Placenta 2012; 33:982-990.
15. 45. Multi-dimensional protein identification technology analysis of syncytiotrophoblast vesicles released from perfused preeclamptic placentas. Pregnancy Hypertens 2012; 2:201-202.
16. American Joint Committee on Cancer: Cancer Staging Manual, 7th edn, SB Edge, DR Byrd, CC Compton, AG Fritz, FL Greene, A Trotti (eds). New York, Springer-Verlag, 2010, p 347.
17. Wong KK, Khatri I, Shaha S, Spanner DE, Gorczynski RM: The role of CD200 in immunity to B cell lymphoma. J Leukoc Biol 2010; 88:361-372.
18. Wong KK, Brennerman F, Chesney A, Spaner DE, Gorczynsiki RM: Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice. Cancer Res 2012; 72:4931-4943.
19. Gorczynski RM, Chen Z, Khatri I, Podnos A, Yu K: Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling. Breast Cancer Res Treat 2013; 142:271-282.
20. Mumm JB, Oft M: Cytokine-based transformation of immune surveillance into tumor-promoting inflammation. Oncogene 2008; 27:5913-5919.
21. Schuh JCL: Trials, tribulation, and trends in tumor modeling in mice. Toxicol Pathol 2004; 32(Suppl 1):53-66.
22. Scott OCA: Tumor transplantation and tumor immunity: a personal view. Cancer Res 1991; 51:757-763.
23. Hewitt HB, Blake ER, Walder AS: A critique of the evidence for active host defence against cancer based on personal studies of 27 murine tumors of spontaneous origin. Br J Cancer 1976; 33:241-249.
24. Rosenberg SA: Progress in human tumor immunology and immunotherapy. Nature 2001; 411:380-384.
25. Humphries C: Honing that killer instinct. Nature 2013; 504:513-515.